This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.  Read our Cookies Policy.
Close
Eye News
  • Features
    • Close
    • Features
    • Allied Professions
    • Humanitarian
    • Interviews
    • AI & Oculomics
    • Ophthalmology
    • Optometry
    • Podcast videos
    • Supplements
  • Education
    • Close
    • Education
    • Learning Curve
    • Quiz
    • Top Tips
    • Trainees
    • Medico-Legal
    • The Truth Behind The Headlines
    • Case Reports
    • Pete's Bogus Journey
  • Reviews
    • Close
    • Reviews
    • Book Reviews
    • Journal Reviews
    • What's trending?
    • Tech Reviews
    • My Top Five
    • The Culture Section
  • Events
  • News
  • Product Guide
  • Industry News
  • Contact us
    • Close
    • Contact us
    • Write for Eye News
  • Home
  • Reviews
  • Journal Reviews
  • Topical nonsteroidal ant-inflammatory drugs (NSAIDs) in patients undergoing cataract surgery

Topical nonsteroidal ant-inflammatory drugs (NSAIDs) in patients undergoing cataract surgery
Reviewed by Kurt Spiteri Cornish

4 February 2021 | Kurt Spiteri Cornish | EYE - Cataract, EYE - Refractive | Postoperative inflammation, cataract surgery, diclofenac, laser flare meter, nepafenac
Share This

Inflammation is a major risk factor for the development of cystoid macular oedema (CMO) after cataract surgery, leading to breakdown of the blood-retina barrier. There is a correlation between severity of CMO and level of postoperative inflammation. Laser flare meter (LFM) is used to quantify the amount of inflammation in the anterior chamber in this single-centre double-blind randomised trial. Sixty-four patients were included in the study. Both Diclofenac (four times daily for four weeks) and Nepafenac (three times daily for three weeks) were effective in controlling anterior chamber flare, but Nepafenac was significantly more effective than Diclofenac at 15 and 30 days after surgery. Macular thickness didn’t vary between the two groups in this study.

Comparison of the effect of Diclofenac 0.1% and Nepafenac 0.1% on aqueous flare in patients undergoing cataract surgery: a prospective randomized study.
Cagini C, Pellegrino A, Cerquaglia A, et al.
CURRENT EYE RESEARCH
2020;45(9):1089-93.
Share This
CONTRIBUTOR
Kurt Spiteri Cornish

Sheffield Teaching Hospitals NHS Trust, London, UK.

View Full Profile
Specialty
  • EYE - Cataract
  • EYE - Cornea
  • EYE - General
  • EYE - Glaucoma
  • EYE - Neuro-ophthalmology
  • EYE - Oculoplastic
  • EYE - Oncology
  • EYE - Orbit
  • EYE - Paediatrics
  • EYE - Pathology
  • EYE - Refractive
  • EYE - Strabismus
  • EYE - Vitreo-Retinal
Archive
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013

Top Of Page

9 Gayfield Square, 
Edinburgh EH1 3NT, UK.

Call: +44 (0)131 557 4184
www.pinpoint-scotland.com

WEBSITE DETAILS
  • Cookie Policy
  • Data Protection Notice
  • Privacy Policy
  • Terms and Conditions
ABOUT US
  • Who we are
  • Register
  • Contact us
  • Contributors
  • Company Awards
DIGITAL ISSUES/GUIDELINES
  • Digital issues - Library
  • Supplements - Library
  • Guidelines
Accreditations
IPSO_FLAG_TEAL 2025.png cpdcertified.png

Pinpoint Scotland Ltd (Registered in Scotland No. SC068684) | © 2025 - Website by Gecko Agency